Tsuchiya, Tomoshi http://orcid.org/0000-0002-8419-1478
Matsumoto, Keitaro
Miyazaki, Takuro
Doi, Ryoichiro
Tokunaga, Shoji
Yamaguchi, Hiroyuki
Tomoshige, Koichi
Watanabe, Hironosuke
Nagayasu, Takeshi
Sugio, Kenji
Funding for this research was provided by:
Taiho Pharmaceutical (AS2018A000786329)
Article History
Received: 22 May 2020
Accepted: 21 February 2021
First Online: 8 March 2021
Declarations
:
: This study was conducted in accordance with the principles expressed in the Declaration of Helsinki. The primary protocol of this study was approved by the central ethics committee of Clinical Research Network Fukuoka Certified Review Board (CRB7180004) on May 2, 2017. Protocol amendments have been made in the study period and the participating institutions. The latest version (version 2) of the study protocol has been reviewed and approved by the Clinical Research Network Fukuoka Certified Review Board on February 5, 2020 (jRCTs071180010). Written informed consent will be obtained from all the participants.
: Not applicable.
: The authors declare no conflicts of interest associated with this manuscript.